B Squared helps biotech and cell & gene therapy companies navigate complex CMC, manufacturing, and sourcing challenges. We bring hands-on expertise, real-world solutions, and a no-nonsense approach to getting things done.
www.bsquared.ch
Cooperation possibilities
B Squared partners with biotech and cell & gene therapy companies to tackle CMC, manufacturing, and sourcing challenges. We offer hands-on support, interim leadership, and strategic guidance to drive projects forward. Whether optimizing supply chains or scaling production, we make things happen.
- https://www.bsquared.ch
- +41 78 244 88 57
- Send an email
- Benoit Bossuge
Some insights
B Squared helps biotech and cell & gene therapy companies deliver life-changing treatments. By optimizing manufacturing, sourcing, and operations, we accelerate innovation and improve access to advanced therapies—bringing real impact to patients and the future of medicine.
At B Squared, we cut through complexity to help biotech and cell & gene therapy companies bring breakthrough treatments to life. We’re proud of our hands-on impact, real-world solutions, and the trust our clients place in us to drive progress where it matters most—helping patients.
Role models in our industry are those pushing the boundaries of biotech and cell & gene therapy, like Carl June for CAR-T innovation, Bob Langer for biomaterials. Anyone turning science into real treatments that change lives inspires us.
Seasoned biopharmaceutical professionals with years of experience in pharmaceutical, biotechnology and cell & gene therapy; we offer expert insights and knowledge to help you navigate through complex challenges, accelerate your growth and deliver measurable results that meet your company's needs.
Our team excels in CMC operations, manufacturing, strategic sourcing, and quality for biotech and cell & gene therapy. We combine deep technical expertise with a hands-on, solution-driven approach. Going forward, we aim to integrate more talent in market access and regulatory strategy.
The Swiss biotech ecosystem can support us best by fostering connections that lead to new business opportunities. By facilitating partnerships, promoting expert-driven solutions, and enabling access to key industry players, it helps us drive impact in biotech and cell & gene therapy.
We want to connect with biotech and cell & gene therapy companies, CDMOs, investors, and technology providers. Engaging with R&D leaders, CMC teams, procurement specialists, and decision-makers in manufacturing and supply chain helps us drive innovation and deliver real impact.